Optics and Optometry of Milano-Bicocca (COMiB), Department of Materials Science - University of Milano-Bicocca
Milan, 20126, Italy
NCT Number: NCT04734522
Non-invasive double-blind randomised comparative study on presbyopic subjects wearing progressive lenses.
Looking for future studies?
Notify Me45 year–70 year
All sexes
Interventional
Not applicable
Milan, 20126, Italy
Background and rationale:
Nowadays many different types of progressive addition lenses are available for the correction of presbyopia. Progressive addition lenses provide a more natural correction for presbyopic people due to a gradual and progressive increase of lens power from far area through the intermediate portion to the near area. However, some patients still experience adaptation problems.
The primary purpose of the study is to evaluate the preference, adaptability and visual performance of progressive lens designs (up to three designs).
Study procedures:
Each participant is required to wear all pairs of spectacles one after another, each pair for one week.
Each participant will be required to visit the optometry clinic (at University of Milano Bicocca) three times:
Visit #1: Screening based on inclusion criteria, Informed Consent Form (ICF) form signing, Optometric exam and choice of the frame.
Subjects who will pass the inclusion/exclusion screening will be asked to sign the ICF and enrolled for the optometric exam. Subjects will choose the spectacle frame and all individual fitting parameters will be measured for lens' manufacturing.
Visit #2: Subjects will receive three marked pairs of progressive lenses. The three spectacle frames will be adjusted to fit properly on the subject' face. After 10-15 min of wearing of the first pair of lenses, each subject will be asked to answer to a questionnaire.
Visit #3 (last visit): questionnaires should be returned; the last comparison question will be answered during this visit, and subject will choose the best pair.
At the end of the study each participant will be entitled to get one pair of progressive lenses available in the market.
Subject population:
Presbyopic subjects have been already wearing any progressive additional lens (PAL) designs.
Number of Subjects:
40 +/- 2 subjects, the specified PAL design wearers and 40 +/- 2 the other PAL design wearers to be enrolled and signed the informed consent form.
Each subject will be wearing three different PAL designs. Subjects will be asked to choose one pair of spectacles (design) which they like the most.
Randomisation:
This study adopts a stratified permuted block randomisation to reduce an evaluation bias by the wearing sequence and prescriptions. The mean of both eyes' prescriptions is set as a single stratification factor.
Frames:
Each subject will choose a model of spectacle frame. Three identical frames will be taken for each subject.
Lenses:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects will be wearing three different PAL designs with different geometries of the optical progression.
Time frame: Entire study duration (approx. 4 weeks)
Evaluate the preference among progressive lens designs through a "First impression questionnaire" after 10-15 minutes of wearing each of the 3 PALs, a "Final satisfaction questionnaire" after 1 week of use of each of the 3 PALs and a "Comparison questionnaire" at the end of the three trial periods of all the three types of PALs.
Time frame: Entire study duration (approx. 4 weeks)
Evaluate adaptability of progressive lens designs through a "Final satisfation questionnaire" after one week of use of each of the three PALs.
Time frame: Entire study duration (approx. 4 weeks)
Evaluate the visual performance of progressive lens designs measured both after 10-15 minutes of wear and after one week by psychophysical analysis (visual acuity at high contrast at near and at distance, rate/accuracy of reading test at high contrast and at near).
University of Milano Bicocca
Other
Acronym: TBPD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07723716
Eye Diseases, Presbyopia
Seoul, South Korea
View Trial DetailsNCT05646719
Eye Diseases, Presbyopia
Phoenix, Arizona, United States
View Trial DetailsNCT07076160
Eye Diseases, Presbyopia
Jacksonville, Florida, United States
View Trial DetailsNCT07570602
Eye Diseases, Presbyopia
Bloomington, Indiana, United States
View Trial Details